Browsing by Author Muñoz Mateu, Montserrat
Showing results 11 to 18 of 18
< previous
Issue Date | Title | Author(s) |
---|---|---|
1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
8-May-2020 | Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study | Fernández de Larrea Baz, Nerea; Pérez Gómez, Beatriz; Guerrero Zotano, Angel; Casas, Ana Ma.; Bermejo de las Heras, Begoña; Baena Cañada, José Manuel; Antolin, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; García Sáenz, José Ángel; Antón, Antonio; Muñoz Mateu, Montserrat; Juan, Ana de; Jara, Carlos; Chacón, José Ignacio; Arcusa, Angels; Gil Gil, Miguel; Adrover, Encarna; Oltra, Amparo; Brunet, Joan; González, Sonia; Bezares, Susana; Lope, Virginia; Martín, Miguel; Pollán, Marina |
18-Dec-2015 | Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. | Prat Aparicio, Aleix; Fan, Cheng; Fernández Martínez, Aranzazu; Hoadley, Katherine A.; Martinello, Rossella; Vidal Losada, Maria Jesús; Viladot, Margarita; Pineda, Estela; Arance, Ana; Muñoz Mateu, Montserrat; Paré, Laia; Cheang, Maggie C. U.; Adamo, Barbara; Perou, Charles M. |
9-Jan-2019 | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial | Gavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix |
1-Oct-2020 | Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype | Lope, Virginia; Guerrero Zotano, Ángel; Casas, Ana; Baena Cañada, José Manuel; Bermejo, Begona; Pérez Gómez, Beatriz; Criado Navarro, Inmaculada; Antolín, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; Antón, Antonio; Castelló, Adela; García Saenz, Jose Angel; Muñoz Mateu, Montserrat; Juan, Ana de; Andrés, Raquel; Llombart Cussac, Antonio; Hernando, Blanca; Franquesa, Rosa María; Caballero, Rosalía; Priego Capote, Feliciano; Martón, Miguel; Pollán, Marina |
7-Jun-2019 | Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis | Pascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic Ruché, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |